Trilinolein is an orally active triglyceride that inhibits the PI3K/Akt, Ras/MEK/ERK signaling pathways, and MMP-2. It can reduce oxidative stress, induce apoptosis, and inhibit cell migration. Trilinolein can be used in the research fields of cardiovascular disease, cerebrovascular disease (such as cerebral ischemia), and non-small cell lung cancer.
- Orally active triglyceride
- Inhibits PI3K/Akt, Ras/MEK/ERK signaling pathways, and MMP-2
- Reduces oxidative stress
- Induces apoptosis
- Inhibits cell migration
- Used in research for cardiovascular disease, cerebrovascular disease, and non-small cell lung cancer